It comes as no surprise that China and India are now surpassing the US and Europe for R&D in drug development.A recent comprehensive report by the Ewing Marion Kauffman Foundation "Globalization of Innovation:Pharmaceuticals,Can India and China Cure the Global Pharmaceutical Market?" notes that originally these countries offered cheap,educated labor pools and an emerging market that could offset the costs of manufacturing of pharmaceuticals in the developed countries,including Europe and the US.And large pharmaceuticals companies outsourced parts of their manufacturing and supply to India and China.
展开▼
机译：尤因·马里昂·考夫曼基金会（Ewing Marion Kauffman Foundation）最近发表的综合报告《全球化的创新：药品，印度和中国能否治愈全球药品市场？》不足为奇，中国和印度现在在药物研发上已经超过美国和欧洲。他指出，这些国家最初提供的廉价，受过教育的劳动力资源以及新兴市场可以抵消包括欧洲和美国在内的发达国家的药品制造成本。大型制药公司将部分生产和服务外包给印度和中国。 。
展开▼
